Movicol and Vectibix drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Movicol (polyethylene glycol 3350) and Vectibix (panitumumab). Common drug interactions include cachexia among females and general physical health deterioration among males.
The phase IV clinical study analyzes what interactions people have when they take Movicol and Vectibix. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
What is Vectibix?
Vectibix has active ingredients of panitumumab. eHealthMe is studying from 8,945 Vectibix users. Check the latest studies of Vectibix.
22 people who take Movicol and Vectibix together, and have interactions are studied.

What are the common drug interactions of Movicol and Vectibix, by gender? *:
female:
- Cachexia (loss of weight)
- Back pain
- Intervertebral disc degeneration (spinal disc degeneration)
- Nausea (feeling of having an urge to vomit)
- Neutropenia (an abnormally low number of neutrophils)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
male:
- General physical health deterioration (weak health status)
- Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
- Infection
- Lymphocyte count decreased
- Mucosal inflammation (infection of mucous membrane)
- Pruritus (severe itching of the skin)
- Rash pustular (redness with pustules)
- Skin fissures (a crack in the skin)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Colon cancer
What are the common drug interactions of Movicol and Vectibix, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
- Dry eye (lack of adequate tears)
- Vision blurred
- Epistaxis (bleed from the nose)
- Fatigue (feeling of tiredness)
- Hypertension (high blood pressure)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Infection
- Lymphocyte count decreased
- Mucosal inflammation (infection of mucous membrane)
50-59:
n/a
60+:
- General physical health deterioration (weak health status)
- Cachexia (loss of weight)
- Febrile neutropenia (fever with reduced white blood cells)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypokalaemia (low potassium)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Intervertebral disc degeneration (spinal disc degeneration)
- Nausea (feeling of having an urge to vomit)
- Neutropenia (an abnormally low number of neutrophils)
What are the existing conditions these people have? *
- Pain: 15 people, 68.18%
- Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 13 people, 59.09%
- Nausea (feeling of having an urge to vomit): 13 people, 59.09%
- High Blood Pressure: 11 people, 50.00%
- Diarrhea: 10 people, 45.45%
- Infection: 8 people, 36.36%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 7 people, 31.82%
- Weight Decreased: 6 people, 27.27%
- Blood Creatinine Increased: 6 people, 27.27%
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 6 people, 27.27%
* Approximation only. Some reports may have incomplete information.
Do you take Movicol and Vectibix?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Movicol and Vectibix:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vectibix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Movicol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vectibix and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 and panitumumab (the active ingredients of Movicol and Vectibix, respectively), and Movicol and Vectibix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Megace cause Bradycardia? - 16 seconds ago
- Could Ramipril cause Urination - Excessive Volume? - 18 seconds ago
- Remicade vs. Sulfadiazine, side effect and effectiveness comparison - 18 seconds ago
- Drug interactions of Lyrica and Q10 - 32 seconds ago
- Drug interactions of Avalide and Zide - 35 seconds ago
- Could Herceptin cause Sputum Discolored? - 39 seconds ago
- Could Tobi cause Anxiety Aggravated? - 43 seconds ago
- Could Catapres cause Procedural Hypertension? - 44 seconds ago
- Drug interactions of Zetia and Levofloxacin - 49 seconds ago
- Could Inlyta cause Flank Pain? - 53 seconds ago